The first thing I ask a surgical device vendor isn't "What does this cost?" It's "What won't you sell me?" A vendor who can honestly name their boundaries is more likely to be trustworthy on the products they do sell. Over the past six years, I've signed off on more than $2.4M in annual purchasing across spine surgery, patient monitoring, and OR equipment. The worst deals I reviewed had one thing in common: a supplier who said yes to everything.
I'm a cost controller, not a surgeon. I can't tell you which spinal implant is clinically superior. But I can tell you which purchasing process leads to lower total cost, fewer surprises, and less friction with the OR team. The best process starts with a question that almost never appears in RFPs: "What do you not do?"
The everything vendor trap
Every supplier wants to be your single source. The problem is that breadth without depth creates gaps. When a company sells spine implants, surgical staplers, patient monitors, and twenty other categories, clinical education and service can get diluted. I'm not saying a large portfolio is automatically bad. I'm saying you should demand proof that the support infrastructure kept pace.
Globus Medical and NuVasive: a useful merger, but check the details
The Globus Medical and NuVasive merger created a broader spine and orthopedics portfolio. From a procurement view, that matters. It can mean fewer contracts, shared sales territories, and more resources for training. But it also means the combined organization is still integrating. Don't buy a "portfolio story" before you've seen the actual clinical assets.
Take a specific product line. If I'm looking at a NuVasive Reline surgical technique PDF, I want to see procedure-specific steps for the Reline system's approach, not generic marketing slides. If that document is easy to find and clearly written, the company is investing in surgeon education. If it's buried, that tells me something about their actual priorities.
What I check before approving any surgical device purchase
I've been doing this long enough to know that the cheapest quote is rarely the cheapest total cost. Here is the mental checklist I use:
- Total cost, not price. I need consignment terms, instrumentation, training, rep coverage, and obsolescence plans in writing. The list price of an implant tells me very little.
- Clinical education resources. Show me what a new surgeon would read before their first case. For NuVasive, that could be a Reline surgical technique PDF. For a patient monitor, that could be a hands-on training session. Depth matters.
- Service and escalation. Who answers the phone when a device fails at 7 p.m.? A vague answer is a red flag.
This is the same logic I use for surgical staplers. The cheapest surgical stapler from a cost perspective isn't necessarily the cheapest in total. Reload pricing, handling, and training all affect the final number. A vendor who cannot separate those line items is guessing. I don't want a guess in the operating room.
Don't assume a bigger product line means better support
I remember comparing dialysis equipment and watching a nurse manager ask, "How does hemodialysis work?" It was a deliberately basic question. One vendor gave a clear, simple explanation; the other gave a sales pitch. Guess which one got the trial? The same principle applies to every device category.
A vendor who says "this isn't our strength" earns my trust
Last year, I reviewed a proposal from a group that sold most of our OR equipment. They didn't get the contract for everything, but one line from their sales director changed how I think:
"This isn't our strength — here's the vendor we'd recommend for that."
They kept the business they could support and lost nothing. I remember that when a supplier says "we do everything" with no boundaries, I get worried.
A lot of procurement mistakes come from assuming that a known name in one category means excellence in another. The Globus Medical and NuVasive merger is a reminder of that. The combined company has real strengths. But strength is still specific. I want a vendor who tells me what they won't do, because that gives me confidence in what they will do.
When to ignore this advice
There are exceptions. If you're a small facility with one surgeon and one procurement officer, splitting purchases among several specialists may create too much overhead. Sometimes the everything vendor is the only practical option. Just know what you're giving up: depth may come at the expense of price and service.
Also, my perspective is procurement, not clinical medicine. I'm not a nephrologist or a spine surgeon, so I can't judge whether one patient monitor or implant is medically better. What I can do is evaluate whether the vendor's offering, training, and service are aligned with your actual needs. If you're making a clinical decision, talk to the clinical team. If you're making a buying decision, ask the unsexy questions.
One more caveat: product portfolios change. The Globus Medical and NuVasive integration isn't done in a day. If you download a NuVasive Reline surgical technique PDF, check the publication date. As of early 2025, this is the way I look at these purchases, but device lists and service models evolve. Verify before you sign.
